Health services and policy research in hepatology

被引:4
作者
Talwalkar, Jayant A. [1 ,2 ,3 ]
机构
[1] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA
[2] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[3] Mayo Clin, William J von Liebig Transplant Ctr, Rochester, MN 55905 USA
关键词
health services research; hepatology; policy; CHRONIC HEPATITIS-C; GENOTYPE; INFECTION; FATTY LIVER-DISEASE; COST-EFFECTIVENESS; UNITED-STATES; HEPATOCELLULAR-CARCINOMA; CARE COORDINATION; VIROLOGICAL RESPONSE; HCV TREATMENT; VIRUS;
D O I
10.1097/MOG.0000000000000064
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose of reviewThis article examines recent health services and policy research studies in hepatology and liver transplantation.Recent findingsCritical issues include access to medical care, timeliness of referral and consultation, resource utilization in clinical practice, comparative effectiveness research, and the evaluation of care delivery models. Despite policymaking efforts, there continues to be unwarranted variation in access to subspecialty care and liver transplantation services based on race and geographic location. Variations in primary care and specialist awareness of practice guidelines for liver disease contribute to disparities in appropriateness and timeliness of treatments. Defining the cost-effectiveness of increased resource utilization for novel antiviral therapies and liver transplantation continues to stimulate controversy. Few comparative effectiveness studies in hepatology exist to date, yet a growing number of analyses using national datasets will help inform policy in this arena. Identifying care delivery models that demonstrate high value for populations with chronic liver disease is critical in the context of recent healthcare reform efforts.SummaryHealth services and policy research is a growing field of investigation in hepatology and liver transplantation. Further emphasis on research training and workforce development in this area will be critical for understanding and improving patient-centered outcomes for this population.
引用
收藏
页码:272 / 278
页数:7
相关论文
共 48 条
[1]   Assessing Variation in the Costs of Care Among Patients Awaiting Liver Transplantation [J].
Axelrod, D. A. ;
Dzebisashvili, N. ;
Lentine, K. ;
Segev, D. L. ;
Dickson, R. ;
Tuttle-Newhall, E. ;
Freeman, R. ;
Schnitzler, M. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (01) :70-78
[2]   The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy [J].
Backx, M. ;
Lewszuk, A. ;
White, J. R. ;
Cole, J. ;
Sreedharan, A. ;
van Sanden, S. ;
Diels, J. ;
Lawson, A. ;
Neal, K. R. ;
Wiselka, M. J. ;
Ito, T. ;
Irving, W. L. .
JOURNAL OF VIRAL HEPATITIS, 2014, 21 (03) :208-215
[3]   The increasing need for health-economic assessment in gastrointestinal and liver diseases Preface [J].
Bardou, Marc ;
Martin, Janet .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2013, 27 (06) :829-830
[4]   Local access to subspecialty care influences the chance of receiving a liver transplant [J].
Barritt, A. Sidney ;
Telloni, Stephen A. ;
Potter, Clarence W. ;
Gerber, David A. ;
Hayashi, Paul H. .
LIVER TRANSPLANTATION, 2013, 19 (04) :377-382
[5]   Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil [J].
Barros F.M.R. ;
Cheinquer H. ;
Tsuchiya C.T. ;
Santos E.A.V. .
Cost Effectiveness and Resource Allocation, 11 (1)
[6]   Awareness and opinions of non-alcoholic fatty liver disease by hospital specialists [J].
Bergqvist, C. -J. ;
Skoien, R. ;
Horsfall, L. ;
Clouston, A. D. ;
Jonsson, J. R. ;
Powell, E. E. .
INTERNAL MEDICINE JOURNAL, 2013, 43 (03) :247-253
[7]   Cost-Effectiveness Analysis of Triple Therapy with Protease Inhibitors in Treatment-Naive Hepatitis C Patients [J].
Blazquez-Perez, Antonio ;
San Miguel, Ramon ;
Mar, Javier .
PHARMACOECONOMICS, 2013, 31 (10) :919-931
[8]   Transarterial Chemoembolization Treatment: Association between Multiple Treatments, Cumulative Expenditures, and Survival [J].
Breunig, Ian M. ;
Shaya, Fadia T. ;
Hanna, Nader ;
Seal, Brian ;
Chirikov, Viktor V. ;
Mullins, C. Daniel .
VALUE IN HEALTH, 2013, 16 (05) :760-768
[9]   Ultrasound Elastography for Fibrosis Surveillance Is Cost Effective in Patients with Chronic Hepatitis C Virus in the UK [J].
Canavan, C. ;
Eisenburg, J. ;
Meng, L. ;
Corey, K. ;
Hur, C. .
DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (09) :2691-2704
[10]   Cost Effectiveness of Direct-Acting Antiviral Therapy for Treatment-Naive Patients With Chronic HCV Genotype 1 Infection in the Veterans Health Administration [J].
Chan, Kee ;
Lai, Mai Ngan ;
Groessl, Erik J. ;
Hanchate, Amresh D. ;
Wong, John B. ;
Clark, Jack A. ;
Asch, Steven M. ;
Gifford, Allen L. ;
Ho, Samuel B. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (11) :1503-1510